These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30388516)

  • 1. The calcineurin regulatory subunit polymorphism and the treatment efficacy of tacrolimus for idiopathic membranous nephropathy.
    Zhu Y; Zhang M; Wang F; Lu J; Chen R; Xie Q; Sun J; Xue J; Hao C; Lin S
    Int Immunopharmacol; 2018 Dec; 65():422-428. PubMed ID: 30388516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin B1 subunit in human peripheral blood mononuclear cells and its role in idiopathic membranous nephropathy.
    Zhu Y; Zhang M; Wang F; Sun J; Lu J; Chen R; Xie Q; Xue J; Hao C; Lin S
    Medicine (Baltimore); 2019 Apr; 98(15):e15231. PubMed ID: 30985728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy.
    Peng L; Wei SY; Li LT; He YX; Li B
    J Formos Med Assoc; 2016 Jan; 115(1):11-8. PubMed ID: 26315481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron-Dense Deposition Patterns and the Outcomes of Nephrotic Idiopathic Membranous Nephropathy Treated with Tacrolimus in Chinese Adults.
    Xiang X; Feng Z; Jiang Q; Huang D; Meng Z; Luo Z
    Med Sci Monit; 2021 Apr; 27():e930500. PubMed ID: 33896931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis.
    Xu P; He YD; Yu ZM; Luo K; Xie HY; Zou PM; Gu X; Wang SR; Cai JF; Xu Q; Li H; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):41-51. PubMed ID: 29532780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis.
    Li YC; Huang J; Li X; Zhao SM
    Nefrologia (Engl Ed); 2019; 39(3):269-276. PubMed ID: 30755327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy.
    Shao L; Jin J; Ye B; Xu B; Li Y; Gong J; Zhang J; Chen M; He Q
    Kidney Blood Press Res; 2019; 44(6):1352-1362. PubMed ID: 31645044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.
    Liu YH; Chen CH; Chen SY; Lin YJ; Liao WL; Tsai CH; Wan L; Tsai FJ
    J Biomed Sci; 2010 Oct; 17(1):81. PubMed ID: 20937089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.
    Shang SL; Cai GY; Duan SW; Li P; Li QG; Chen XM
    BMC Nephrol; 2018 Jul; 19(1):182. PubMed ID: 30021637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis.
    Santosh T; Liu H; Liu B
    Chin Med J (Engl); 2014; 127(14):2693-9. PubMed ID: 25043091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to immunosuppressive therapy in PLA
    Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
    BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development.
    Wang B; Yang H; Shen L; Wang J; Pu W; Chen Z; Shen X; Fu J; Zhuang Z
    Cell Physiol Biochem; 2016; 40(1-2):391-399. PubMed ID: 27866197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study.
    Rui M; Jiang L; Pan JJ; Huang XT; Cui JF; Zhang SJ; He SM; Han HH; Chen X; Wang DD
    Int Urol Nephrol; 2024 Sep; 56(9):3047-3055. PubMed ID: 38642210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
    Chen M; Zhang X; Xiong Y; Xu G
    Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'UTR variants of TNS3, PHLDB1, NTN4, and GNG2 genes are associated with IgA nephropathy risk in Chinese Han population.
    Feng Y; Su Y; Ma C; Jing Z; Yang X; Zhang D; Xie M; Li W; Wei J
    Int Immunopharmacol; 2019 Jun; 71():295-300. PubMed ID: 30928649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.